Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias

Simple item page
dc.contributor.authorCheshire, P.
dc.contributor.authorAyton, S.
dc.contributor.authorBertram, K.L.
dc.contributor.authorLing, H.
dc.contributor.authorLi, A.
dc.contributor.authorMcLean, C.
dc.contributor.authorHalliday, G.M.
dc.contributor.authorO'Sullivan, S.S.
dc.contributor.authorRevesz, T.
dc.contributor.authorFinkelstein, D.I.
dc.contributor.authorStorey, E.
dc.contributor.authorWilliams, D.R.
dc.date.issued2015
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityPerdita Cheshire, Scott Ayton, Kelly L. Bertram, Helen Ling, Abi Li, Catriona McLean, Glenda M. Halliday, Sean S. O’Sullivan, Tamas Revesz, David I. Finkelstein, Elsdon Storey and David R. Williams
dc.identifier.citationMovement Disorders, 2015; 30(6):796-804
dc.identifier.doi10.1002/mds.26144
dc.identifier.issn0885-3185
dc.identifier.issn1531-8257
dc.identifier.orcidRevesz, T. [0000-0003-2501-0259]
dc.identifier.urihttp://hdl.handle.net/2440/121063
dc.language.isoen
dc.publisherWiley
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/630434
dc.rights© 2015 International Parkinson and Movement Disorder Society
dc.source.urihttps://doi.org/10.1002/mds.26144
dc.subjectParkinson’s disease; levodopa-induced dyskinesias; serotonin; dopamine; striatum
dc.titleSerotonergic markers in Parkinson's disease and levodopa-induced dyskinesias
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications